One-Year Open-Label Safety and Efficacy Study of Paliperidone Extended-Release Tablets in Patients With Schizophrenia
Michelle Kramer, MD, MPH, George Simpson, MD, Valentinas Maciulis, MD, PhD, Stuart Kushner, MD, Yanning Liu, MS, Pilar Lim, PhD, David Hough, MD,
Joseph Palumbo, MD, and Mariëlle Eerdekens, MD, MBA
Schizophrenia is a chronic illness that requires long-term treatment in most cases. Approximately 40% of schizophrenia patients are noncompliant with their medication regimen at any given time. more... |